Your browser doesn't support javascript.
loading
Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva.
Howitt, Brooke E; Sun, Heather H; Roemer, Margaretha G M; Kelley, Alyssa; Chapuy, Bjoern; Aviki, Emeline; Pak, Christine; Connelly, Courtney; Gjini, Evisa; Shi, Yunling; Lee, Larissa; Viswanathan, Akila; Horowitz, Neil; Neuberg, Donna; Crum, Christopher P; Lindeman, Neal L; Kuo, Frank; Ligon, Azra H; Freeman, Gordon J; Hodi, F Stephen; Shipp, Margaret A; Rodig, Scott J.
Afiliação
  • Howitt BE; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Sun HH; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Roemer MG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston Massachusetts.
  • Kelley A; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Chapuy B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston Massachusetts.
  • Aviki E; Departments of Obstetrics and Gynecology, Radiation Oncology, and Gynecological Oncology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Pak C; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Connelly C; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Gjini E; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston Massachusetts4The Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Shi Y; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Lee L; Departments of Obstetrics and Gynecology, Radiation Oncology, and Gynecological Oncology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Viswanathan A; Departments of Obstetrics and Gynecology, Radiation Oncology, and Gynecological Oncology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Horowitz N; Departments of Obstetrics and Gynecology, Radiation Oncology, and Gynecological Oncology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Neuberg D; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Crum CP; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Lindeman NL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Kuo F; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Ligon AH; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston Massachusetts4The Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston Massachusetts4The Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston Massachusetts4The Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts4The Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
JAMA Oncol ; 2(4): 518-22, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26913631
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Vulvares / Carcinoma de Células Escamosas / Neoplasias do Colo do Útero / Antígeno B7-H1 / Proteína 2 Ligante de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Vulvares / Carcinoma de Células Escamosas / Neoplasias do Colo do Útero / Antígeno B7-H1 / Proteína 2 Ligante de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article